CCL

Összesen 2 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM049160
035-os BibID:PMID:21984254
Első szerző:Almássy János (élettanász, biológus, angol-magyar szakfordító)
Cím:The LRRC26 protein selectively alters the efficacy of BK channel activators / Janos Almassy, Ted B. Begenisich
Dátum:2012
ISSN:0026-895X
Megjegyzések:Large conductance, Ca2+-activated K channel proteins are involved in a wide range of physiological activities, so there is considerable interest in the pharmacology of large conductance calcium-activated K (BK) channels. One potent activator of BK channels is mallotoxin (MTX), which produces a very large hyperpolarizing shift of the voltage gating of heterologously expressed BK channels and causes a dramatic increase in the activity of BK channels in human smooth muscle cells. However, we found that MTX shifted the steady-state activation of BK channels in native parotid acinar cells by only 6 mV. This was not because the parotid BK isoform (parSlo) is inherently insensitive to MTX as MTX shifted the activation of heterologously expressed parSlo channels by 70 mV. Even though MTX had a minimal effect on steady-state activation of parotid BK channels, it produced an approximate 2-fold speeding of the channel-gating kinetics. The BK channels in parotid acinar cells have a much more hyperpolarized voltage activation range than BK channels in most other cell types. We found that this is probably attributable to an accessory protein, LRRC26, which is expressed in parotid glands: expressed parSlo + LRRC26 channels were resistant to the actions of MTX. Another class of BK activators is the benzimidazalones that includes 1,3-dihydro-1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-2H-benzimidazol-2-one (NS-1619). Although the LRRC26 accessory protein strongly inhibited the ability of MTX to activate BK channels, we found that it had only a small effect on the action of NS-1619 on BK channels. Thus, the LRRC26 BK channel accessory protein selectively alters the pharmacology of BK channels.
Tárgyszavak:Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
parotid cell
Megjelenés:Molecular Pharmacology. - 81 : 1 (2012), p. 21-30. -
További szerzők:Begenisich, Ted B.
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM080522
035-os BibID:(WOS)000480733000011 (Scopus)85071351221 (PMID)31337666
Első szerző:Diszházi Gyula (gyógyszerész)
Cím:Dantrolene Requires Mg2+ and ATP To Inhibit the Ryanodine Receptor / Gyula Diszházi, Zsuzsanna Édua Magyar, János András Mótyán, László Csernoch, István Jóna, Péter Pál Nánási, János Almássy
Dátum:2019
ISSN:0026-895X
Megjegyzések:Dantrolene is a ryanodine receptor (RyR) inhibitor, which is used to relax muscles in malignant hyperthermia syndrome. Although dantrolene binds to the RyR protein, its mechanism of action is unknown, mainly because of the controversial results showing that dantrolene inhibited Ca2+ release from intact fibers and sarcoplasmic reticulum (SR) vesicles, but failed to inhibit single RyR channel currents in bilayers. Accordingly, it was concluded that an important factor for dantrolene's action was lost during the purification procedure of RyR. Recently, Mg2+ was demonstrated to be the essential factor for dantrolene to inhibit Ca2+ release in skinned muscle fibers. The aim of the present study was confirm these results in Ca2+ release and bilayer experiments, using SR vesicles and solubilized channels, respectively. Our Ca2+ release experiments demonstrated that the effect of dantrolene and Mg2+ was cooperative and that ATP enhanced the inhibiting effect of dantrolene. Namely, 10 mu M dantrolene reduced RyR channel open probability by similar to 50% in the presence of 3 mM free Mg2+ and 1 mMATP, whereas channel activity further decreased to similar to 20% of control when [ATP] was increased to 2 mM. Our data provide important complementary information that supports the direct, Mg2+-dependent mechanism of dantrolene's action and suggests that dantrolene also requires ATP to inhibit RyR.
Tárgyszavak:idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Molecular Pharmacology. - 96 : 3 (2019), p. 401-407. -
További szerzők:Magyar Zsuzsanna Édua (1993-) (molekuláris biológus) Mótyán János András (1981-) (biokémikus, molekuláris biológus) Csernoch László (1961-) (élettanász) Jóna István (1948-) (élettanász, fizikus) Nánási Péter Pál (1956-) (élettanász) Almássy János (1981-) (élettanász, biológus, angol-magyar szakfordító)
Pályázati támogatás:PD112199
OTKA
K115397
OTKA
GINOP-2.3.2-15-2016-00040
GINOP
EFOP-3.6.2-16-2017-00006
EFOP
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1